Thyrocare Technologies Limited

Price Chart

Risk-Adjusted Performance

Thyrocare Technologies Limited (THYROCARE) Price Performance

Thyrocare Technologies Limited (THYROCARE) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR387.50, down 0.40% from the previous close.

Over the past year, THYROCARE has traded between a low of INR349.55 and a high of INR306135.32. The stock has lost 13.2% over this period. It is currently 99.9% below its 52-week high.

Thyrocare Technologies Limited has a market capitalization of $62.76B, with a price-to-earnings ratio of 45.85.

About Thyrocare Technologies Limited

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.